Recombinant Anti-CD3 x Anti-gpA33 Bispecific Antibody (scFv-Fc) (BSCFV-086)

Recombinant Anti-CD3 x Anti-gpA33 Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-CD3 specificity or anti-gpA33 specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Non-Hodgkin's lymphoma (NHL) therapy.

Datasheet INQUIRY

Specifications

Targets

CD3 & gpA33

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Non-Hodgkin's lymphoma (NHL)

Targets

Target 1

CD3

Gene ID

916

UniProt ID

P07766

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Target 2

gpA33

Gene ID

10223

UniProt ID

Q99795

Alternative Names

GPA33; glycoprotein A33; glycoprotein A33 (transmembrane); A33; cell surface A33 antigen; transmembrane glycoprotein A33

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-gpA33 Bispecific Antibody (scFv-Fc) (BSCFV-086). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD3 x Anti-gpA33 Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-086)

Specifications

Targets

Customer Reviews and Q&As